The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models

BACKGROUND: Interventions to protect young infants against respiratory syncytial virus (RSV) are in advanced phases of development and are expected to be available in the foreseeable future. Gavi, the Vaccine Alliance, included maternal vaccines and infant monoclonal antibodies for RSV as part of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Baral, Ranju, Li, Xiao, Willem, Lander, Antillon, Marina, Vilajeliu, Alba, Jit, Mark, Beutels, Philippe, Pecenka, Clint
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342012/
https://www.ncbi.nlm.nih.gov/pubmed/32586761
http://dx.doi.org/10.1016/j.vaccine.2020.06.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342012/
https://www.ncbi.nlm.nih.gov/pubmed/32586761
http://dx.doi.org/10.1016/j.vaccine.2020.06.036

Ejemplares similares